Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04805866 · ClinicalTrials.gov registry record

Tracking Neural Synergies After Stroke.

A clinical trial of Stroke, sponsored by Shirley Ryan AbilityLab.

Active
Registry status
36
Enrollment target
1
Study location

NCT04805866: Active study of Stroke, sponsored by Shirley Ryan AbilityLab.

NCT04805866 is a study of Stroke that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 36 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04805866, a study of Stroke, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.

ACTIVE NOT RECRUITING
Registry status
36 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to identify neural muscle synergies of patients post-stroke and track them during an inpatient acute rehabilitation. To this end, the researchers will use an innovative approach based on the identification of large populations of motor units from recordings of surface high-density electromyography (HD-EMG).

Conditions Studied

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2021-06-09
Est. Completion 2025-07-31

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT04805866

The ClinicalTrials.gov registry entry for NCT04805866 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT04805866 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04805866 about?

NCT04805866 is a clinical study titled "Tracking Neural Synergies After Stroke.". The purpose of this study is to identify neural muscle synergies of patients post-stroke and track them during an inpatient acute rehabilitation. To this end, the researchers will use an innovative approach based on the identification of large populations of motor units from recordings of surface hi...

What is the current status of trial NCT04805866?

This trial is currently active not recruiting. The enrollment target is 36 participants. The study started on 2021-06-09. Estimated completion is 2025-07-31.

What conditions does trial NCT04805866 study?

This clinical trial studies the following conditions: Stroke.

Who is sponsoring clinical trial NCT04805866?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04805866 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.